Clinical and Medical Engineering Live
- ISSN: 2997-612X
Alexandre Camilotti Gasperin, Enrico Guido Oliveira Minniti, Felipe Lopes Grillo*, Felipe Storm Ross, Gabriel Della Torres Marinho, et al,.
Introduction: Ménière's Disease (MD), first described by Prosper Ménière in 1861, is an inner ear condition associated with
Endolymphatic Hydrops (EH). MD is characterized by episodic vertigo, fluctuating hearing loss, tinnitus, and aural fullness.
Currently, the treatment for MD focuses on symptom management, but there is no definitive cure.
Objective: This study aims to evaluate the use of Nimodipine as an alternative treatment for MD and EH, analyzing its efficacy
in reducing vertigo episodes and improving patients' quality of life.
Methods: A retrospective study was conducted with 30 patients diagnosed with MD and EH. These patients were treated with
Nimodipine over a period of 6 months. The study evaluated the frequency of vertigo episodes, hearing improvement, and the
presence of tinnitus before and after treatment. Patients were followed in a specialized clinic in southern brazil from 2003 to
2019.
Results: The results demonstrated a significant reduction in the frequency of vertigo episodes in patients treated with Nimodipine.
Additionally, there was an improvement in hearing levels and a reduction in tinnitus intensity. Conclusion: Nimodipine presents
as a promising alternative treatment for MD and EH, contributing to the reduction of vertigo episodes and improving patients'
quality of life. However, further studies with larger sample sizes and longer follow-up periods are needed to confirm these
findings.